NCT00053430View on ClinicalTrials.gov

Using the Drug Thalidomide to Stimulate T Cells in HIV-Infected People

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 30, 2001

Primary Completion Date

August 31, 2005

Study Completion Date

February 28, 2006

Conditions
HIV Infections
Interventions
DRUG

Thalidomide

Tablet taken orally daily

DRUG

Thalidomide placebo

Placebo tablet taken orally daily

Trial Locations (1)

33125

University of Miami School of Medicine, Miami

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00053430 - Using the Drug Thalidomide to Stimulate T Cells in HIV-Infected People | Biotech Hunter | Biotech Hunter